AAAAAA

   
Results: 1-10 |
Results: 10
Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
Authors: Tacket, CO Galen, J Sztein, MB Losonsky, G Wyant, TL Nataro, J Wasserman, SS Edelman, R Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C, CLIN IMMUNO, 97(2), 2000, pp. 146-153
Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
Authors: Tacket, CO Mason, HS Losonsky, G Estes, MK Levine, MM Arntzen, CJ
Citation: Co. Tacket et al., Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes, J INFEC DIS, 182(1), 2000, pp. 302-305
Role of EspB in experimental human enteropathogenic Escherichia coli infection
Authors: Tacket, CO Sztein, MB Losonsky, G Abe, A Finlay, BB McNamara, BP Fantry, GT James, SP Nataro, JP Levine, MM Donnenberg, MS
Citation: Co. Tacket et al., Role of EspB in experimental human enteropathogenic Escherichia coli infection, INFEC IMMUN, 68(6), 2000, pp. 3689-3695
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201
Phase II safety and immunogenicity study of live chikungunya virus vaccineTSI-GSD-218
Authors: Edelman, R Tacket, CO Wasserman, SS Bodison, SA Perry, JG Mangiafico, JA
Citation: R. Edelman et al., Phase II safety and immunogenicity study of live chikungunya virus vaccineTSI-GSD-218, AM J TROP M, 62(6), 2000, pp. 681-685
A review of oral vaccination with transgenic vegetables
Authors: Tacket, CO Mason, HS
Citation: Co. Tacket et Hs. Mason, A review of oral vaccination with transgenic vegetables, MICROBES IN, 1(10), 1999, pp. 777-783
Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device
Authors: Tacket, CO Roy, MJ Widera, G Swain, WF Broome, S Edelman, R
Citation: Co. Tacket et al., Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device, VACCINE, 17(22), 1999, pp. 2826-2829
Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milkproduct against enterotoxigenic Escherichia coli challenge administered during a standard meal
Authors: Tacket, CO Losonsky, G Livio, S Edelman, R Crabb, J Freedman, D
Citation: Co. Tacket et al., Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milkproduct against enterotoxigenic Escherichia coli challenge administered during a standard meal, J INFEC DIS, 180(6), 1999, pp. 2056-2059
Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama
Authors: Taylor, DN Sanchez, JL Castro, JM Lebron, C Parrado, CM Johnson, DE Tacket, CO Losonsky, GA Wasserman, SS Levine, MM Cryz, SJ
Citation: Dn. Taylor et al., Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama, INFEC IMMUN, 67(4), 1999, pp. 2030-2034
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination
Authors: Tacket, CO Cohen, MB Wasserman, SS Losonsky, G Livio, S Kotloff, K Edelman, R Kaper, JB Cryz, SJ Giannella, RA Schiff, G Levine, MM
Citation: Co. Tacket et al., Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination, INFEC IMMUN, 67(12), 1999, pp. 6341-6345
Risultati: 1-10 |